The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

The global hepatitis c testing market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...

Objective Hepatitis B virus (HBV) can integrate into the chromosomes of infected ... 2 at room temperature for 30 mins and then incubated with primary HBsAg and HBcAg antibody (Origene) at 37°C for 60 ...

In addition to HBsAg, other viral markers such as hepatitis B core-related antigen (HBcrAg) are available, but their potential association with HBV-specific immune responses is not defined yet, which ...

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, ...

It can only cause disease in people who are infected with the hepatitis B virus (HBV) because HDV cannot replicate without HBV being present. Hepatitis D is mostly seen in developing nations where ...

THE WEEK’S MOST POPULAR CURRENT R&B/HIP-HOP SONGS ACROSS ALL GENRES ... Kendrick Lamar & SZA Last week Weeks at no. 1 Weeks on chart K.L.Duckworth, S.I.Rowe, A.Boggs, S.J.Dew, M.A.Spears ...

A recent case has been reported in Medicine of a patient with generalized pustular psoriasis (GPP) and hepatitis B whose flares were successfully ... “Spesolimab, an anti-IL-36 receptor monoclonal ...

Countries such as Thailand, Malaysia, Sri Lanka, and the Maldives have already achieved dual elimination of HIV and syphilis transmission from mother to child and are preparing for hepatitis B ...

Management is confident after Kimmtrak in combination with AstraZeneca’s (AZN) anti-PD-L1 antibody Imfinzi (durvalumab ... which targets hepatitis B virus. Initial early stage results are ...